Tevogen Bio (TVGN) Stock Chart & Stock Price History → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free TVGN Stock Alerts $0.81 +0.03 (+3.86%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrendsStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends Tevogen Bio Stock Price Performance5 Day Performance-1.52%1 Month Performance-16.75%3 Month Performance-88.55% Receive TVGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tevogen Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. TVGN Stock Chart for Saturday, June, 1, 2024 TVGN Chart by TradingView Tevogen Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.77$0.81+4.33%$0.81$0.7695,053 shs$12.78 million05/30/2024$0.80$0.77-2.89%$0.82$0.7599,955 shs$12.24 million05/29/2024$0.79$0.80+0.45%$0.82$0.7767,370 shs$12.61 million05/28/2024$0.82$0.79-3.24%$0.82$0.7974,104 shs$12.55 million05/27/2024$0.82$0.82$0.84$0.78127,300 shs$12.97 million05/24/2024$0.82$0.82$0.84$0.78125,415 shs$12.97 million Get the Latest News and Ratings for TVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tevogen Bio and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.77$0.82+5.85%$0.84$0.75251,937 shs$12.97 million05/22/2024$0.86$0.77-9.92%$0.81$0.77249,357 shs$12.26 million05/21/2024$0.78$0.86+10.26%$0.86$0.791.57 million shs$13.61 million05/20/2024$0.82$0.78-4.88%$0.85$0.76285,377 shs$12.34 million05/17/2024$0.89$0.82-7.87%$0.91$0.80426,448 shs$12.97 million05/16/2024$0.97$0.89-8.20%$0.95$0.89363,746 shs$14.08 million05/15/2024$0.92$0.97+5.38%$1.00$0.90652,169 shs$15.34 million05/14/2024$1.00$0.92-8.00%$1.02$0.901.57 million shs$14.55 million05/13/2024$0.98$1.00+1.57%$1.48$0.9821.05 million shs$15.82 million05/10/2024$0.99$0.98-0.70%$1.00$0.9651,547 shs$15.58 million05/09/2024$1.00$0.99-0.86%$1.02$0.97134,402 shs$15.68 million05/08/2024$0.99$1.00+0.96%$1.00$0.9686,168 shs$15.82 million05/07/2024$0.96$0.99+3.18%$1.01$0.95221,026 shs$15.67 million05/06/2024$0.97$0.96-1.03%$0.99$0.95115,957 shs$15.19 million05/03/2024$0.99$0.97-2.02%$1.00$0.9574,078 shs$15.35 million05/02/2024$0.97$0.99+2.06%$1.03$0.9686,527 shs$15.66 million05/01/2024$1.00$0.97-3.00%$1.05$0.93181,605 shs$15.35 million04/30/2024$1.00$1.00+0.01%$1.05$0.96238,200 shs$15.82 million04/29/2024$1.00$1.00-0.01%$1.05$0.86724,431 shs$15.82 million04/26/2024$0.85$1.00+17.65%$1.20$0.9310.77 million shs$15.82 million04/25/2024$1.50$0.85-43.33%$1.54$0.80121,426 shs$13.45 million04/24/2024$1.65$1.50-9.09%$1.79$1.46400,315 shs$23.73 million04/23/2024$1.67$1.65-1.20%$1.68$1.49102,094 shs$26.10 million04/22/2024$1.85$1.67-9.73%$1.85$1.6533,983 shs$26.42 million04/19/2024$2.12$1.85-12.74%$2.16$1.75209,821 shs$29.27 million04/18/2024$2.29$2.12-7.42%$2.23$2.1044,602 shs$33.54 million04/17/2024$2.36$2.29-2.97%$2.42$2.2363,831 shs$36.23 million04/16/2024$2.35$2.36+0.43%$2.40$2.2526,948 shs$37.34 million04/15/2024$2.45$2.35-4.08%$2.53$2.30207,062 shs$37.18 million04/12/2024$2.47$2.45-0.81%$2.49$2.36180,015 shs$38.76 million04/11/2024$2.45$2.47+0.82%$2.73$2.22398,499 shs$39.08 million04/10/2024$2.35$2.45+4.26%$2.57$2.34238,218 shs$38.76 million04/09/2024$2.70$2.35-12.96%$2.62$2.24242,327 shs$37.18 million04/08/2024$2.92$2.70-7.53%$3.08$2.61192,231 shs$42.71 millionThe only financial event in 2024 that matters (Ad)Man Who Predicted 2008 Crash Warns of Black Swan Financial Event in 2024 Porter Stansberry’s new documentary is going viral.Stream the documentary for free by clicking here04/05/2024$3.40$2.92-14.12%$3.44$2.84508,209 shs$46.19 million04/04/2024$2.62$3.40+29.78%$4.78$2.9519.06 million shs$53.79 million04/03/2024$2.95$2.62-11.19%$2.98$2.5815,459 shs$41.45 million04/02/2024$3.23$2.95-8.55%$3.34$2.949,990 shs$46.66 million04/01/2024$3.75$3.23-13.98%$3.79$3.1749,182 shs$51.03 million03/29/2024$3.75$3.75$3.75$3.4514,276 shs$59.32 million03/28/2024$3.47$3.75+8.05%$3.75$3.4514,276 shs$59.32 million03/27/2024$3.75$3.47-7.45%$4.00$3.3614,545 shs$54.89 million03/26/2024$3.97$3.75-5.54%$4.05$3.5018,242 shs$59.33 million03/25/2024$4.38$3.97-9.38%$4.51$3.977,220 shs$62.81 million03/22/2024$4.27$4.26-0.23%$4.52$4.204,433 shs$67.38 million03/21/2024$4.44$4.27-3.83%$4.72$4.278,570 shs$67.55 million03/20/2024$4.54$4.44-2.20%$4.75$4.443,369 shs$70.24 million03/19/2024$4.85$4.54-6.39%$5.42$4.5414,760 shs$71.82 million03/18/2024$6.17$4.85-21.39%$6.25$4.8539,871 shs$76.73 million03/15/2024$6.50$6.17-5.08%$6.53$5.6532,257 shs$97.61 million03/14/2024$6.50$6.50$6.50$6.054,027 shs$102.83 million03/13/2024$6.68$6.50-2.62%$6.50$6.091,443 shs$102.83 million03/12/2024$6.55$6.68+1.91%$6.95$6.406,571 shs$105.57 million03/11/2024$7.00$6.55-6.43%$7.61$6.346,280 shs$103.62 million03/08/2024$7.38$7.00-5.15%$7.22$6.5910,864 shs$110.71 million03/07/2024$7.66$7.38-3.66%$7.73$7.224,485 shs$116.75 million03/06/2024$7.72$7.66-0.78%$8.35$7.0213,964 shs$121.18 million03/05/2024$7.82$7.72-1.28%$8.49$6.946,650 shs$122.13 million03/04/2024$7.05$7.82+10.92%$7.82$6.605,547 shs$123.71 million03/01/2024$7.77$7.05-9.27%$8.26$7.0511,754 shs$111.53 million02/29/2024$7.71$7.77+0.78%$8.30$7.775,681 shs$122.92 million Related Companies: Aligos Therapeutics Stock Chart IN8bio Stock Chart OKYO Pharma Stock Chart Brainstorm Cell Therapeutics Stock Chart Achilles Therapeutics Stock Chart Quince Therapeutics Stock Chart Estrella Immunopharma Stock Chart NKGen Biotech Stock Chart Surrozen Stock Chart MiNK Therapeutics Stock Chart Receive TVGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tevogen Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVGN) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.